Rhythm Biosciences Limited (ASX:RHY)
Australia · Delayed Price · Currency is AUD 0.0900
-0.0010 (-1.10%)
Sep 26, 2025, 4:10 PM AEST
Rhythm Biosciences Company Description
Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia.
The company develops ColoSTAT, a blood test for the early detection of colorectal cancer. It also acquired Genetype to expand product offerings.
Rhythm Biosciences Limited was incorporated in 2017 and is headquartered in Parkville, Australia.
Rhythm Biosciences Limited
| Country | Australia |
| Founded | 2017 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| CEO | David Atkins |
Contact Details
Address: Bio21 Institute Parkville, 3010 Australia | |
| Phone | 61 3 8256 2880 |
| Website | rhythmbio.com |
Stock Details
| Ticker Symbol | RHY |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000RHY2 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Dr. David Atkins M.B.A., Ph.D. | Chief Executive Officer and Director |
| Todd Perkinson | Chief Financial Officer |